Repron Therapeutics
Latest round
- Seed
Last raised
- Jun 2023
Total raised
- $2.2M
Investors
- 3
About Repron Therapeutics
Founded in 2023 and based in Milan, Italy, Repron Therapeutics operates as an epigenetic silencing regulator to intercept and eliminate residual tumor cells at the primary site or micro-metastases in target organs. Repron Therapeutics is a developer of a healthcare technology intended to inhibit the activity of oncogenes on the basis of tumor malignancy through the use of engineered synthetic factors. The company aims to provide treatments for solid tumor cases where complete surgical removal is not feasible, and the risk of metastasis or recurrence is high, providing patients with epigenetic silencing regulations to intercept and eliminate residual tumor cells at the primary site or micro-metastases in target organs.
Who invested in Repron Therapeutics
3 investors across 1 round
See all investors in Repron Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jun 16, 2023
Amount
$2.2M
Investors
Questions about Repron Therapeutics
Who invested in Repron Therapeutics?
Repron Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Repron Therapeutics raised?
Repron Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Repron Therapeutics last raise money?
Repron Therapeutics's most recent round on record is a Seed, in Jun 2023.
What does Repron Therapeutics do?
Founded in 2023 and based in Milan, Italy, Repron Therapeutics operates as an epigenetic silencing regulator to intercept and eliminate residual tumor cells at the primary site or micro-metastases in target organs.
Where is Repron Therapeutics headquartered?
Repron Therapeutics is headquartered in Milan, Italy.
Which VCs invest in companies like Repron Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Repron Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Repron Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.